Additionally, some tissue-specific biomarkers have been associated with breast cancer risk in specific subsets of women, such as insulin-like growth factor 1 receptor (IGF1R), and more recently, the combination of Ki67 and estrogen receptor (ER) expression in a subset of women [6–8]. This evidence concerns the gene MKI67 and breast carcinoma.